These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27449098)

  • 1. Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
    Pickl JM; Tichy D; Kuryshev VY; Tolstov Y; Falkenstein M; Schüler J; Reidenbach D; Hotz-Wagenblatt A; Kristiansen G; Roth W; Hadaschik B; Hohenfellner M; Duensing S; Heckmann D; Sültmann H
    Oncotarget; 2016 Sep; 7(37):59589-59603. PubMed ID: 27449098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
    Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ
    J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7.
    Chen J; Zhao Y; Zhang F; Li J; Boland JA; Cheng NC; Liu K; Tiffen JC; Bertolino P; Bowen DG; Krueger A; Lisowski L; Alexander IE; Vadas MA; El-Omar E; Gamble JR; McCaughan GW
    Cell Mol Life Sci; 2022 Jul; 79(8):443. PubMed ID: 35867177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma.
    Xie D; Shang C; Zhang H; Guo Y; Tong X
    Med Sci Monit; 2015 Jan; 21():225-30. PubMed ID: 25596753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy.
    Touchaei AZ; Vahidi S; Samadani AA
    Med Oncol; 2023 Dec; 41(1):21. PubMed ID: 38112798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.
    Forzati F; De Martino M; Esposito F; Sepe R; Pellecchia S; Malapelle U; Pellino G; Arra C; Fusco A
    BMC Cancer; 2017 Mar; 17(1):170. PubMed ID: 28259135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of circGOLPH3 and its binding protein CBX7 on the proliferation and apoptosis of prostate cancer cells.
    Gong L; Tang Y; Jiang L; Tang W; Luo S
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.
    Federico A; Sepe R; Cozzolino F; Piccolo C; Iannone C; Iacobucci I; Pucci P; Monti M; Fusco A
    Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):509-521. PubMed ID: 30826432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
    Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M
    Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
    Xuan H; Xue W; Pan J; Sha J; Dong B; Huang Y
    Biochemistry (Mosc); 2015 Mar; 80(3):276-83. PubMed ID: 25761682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells.
    Zhang Y; Tedja R; Millman M; Wong T; Fox A; Chehade H; Gershater M; Adzibolosu N; Gogoi R; Anderson M; Rutherford T; Zhang Z; Chopp M; Mor G; Alvero AB
    J Ovarian Res; 2023 Nov; 16(1):233. PubMed ID: 38037081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.
    Yu T; Wu Y; Hu Q; Zhang J; Nie E; Wu W; Wang X; Wang Y; Liu N
    Oncotarget; 2017 Apr; 8(16):26637-26647. PubMed ID: 28460453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crosstalk between lncRNA-SNHG7/miRNA-181/cbx7 Modulates Malignant Character in Lung Adenocarcinoma.
    Pei YF; He Y; Hu LZ; Zhou B; Xu HY; Liu XQ
    Am J Pathol; 2020 Jun; 190(6):1343-1354. PubMed ID: 32201260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
    Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
    Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
    Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
    Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nanoplatform-based circCSNK1G3 affects CBX7 protein and promotes glioma cell growth.
    Qiu CJ; Hu LY; Yang J; Cao JJ; Pei BG; Dai RR; Pan SJ
    Int J Biol Macromol; 2024 Sep; 276(Pt 2):134025. PubMed ID: 39033888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.